Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis

Creative Commons License

Demir C. F., Balgetir F., Ethemoglu O., Aksoy D., Aktas F., Koca S. S., ...Daha Fazla

ARCHIVES OF RHEUMATOLOGY, cilt.36, sa.2, ss.219-226, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 2
  • Basım Tarihi: 2021
  • Doi Numarası: 10.46497/archrheumatol.2021.8229
  • Dergi Adı: ARCHIVES OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.219-226
  • Anahtar Kelimeler: Colchicine, resistant familial Mediterranean fever, familial Mediterranean fever, multiple sclerosis, ocrelizumab
  • Erciyes Üniversitesi Adresli: Evet

Özet

Objectives: This study aims to evaluate the effects of ocrelizumab (OCZ) on familial Mediterranean fever (FMF) attacks in multiple sclerosis (MS) patients with FMF (MS+FMF patients).